 surfact replac therapi singl postventilatori dose reconstitut bovin surfact preterm neonat respiratori distress syndrom final analysi multicent double-blind trial comparison similar trial surfactant-ta studi group effect singl dose surfact TA prematur neonat birth respiratori distress syndrom rd multicent double-blind clinic trial surfact defici ultrasonograph evid intracrani hemorrhag equal II fifty-four patient surfact mg phospholipid kilogram bodi weight patient air placebo hour life treatment surfact signific reduct sever rd concomit increas proport neonat mild diseas frequenc pulmonari interstiti emphysema pneumothorax treat neonat control neonat vs vs frequenc intracrani hemorrhag surfact group control group vs neonat surfact group vs categor sever intracrani hemorrhag sever bronchopulmonari dysplasia surfact group signific advantag cochran-mantel-haenszel proport neonat intracrani hemorrhag and/or bronchopulmonari dysplasia surfact group control group neonat surfact group control group differ group respect frequenc patent ductu arteriosu vs pulmonari hemorrhag vs enterocol vs sepsi vs retinopathi prematur vs death vs treatment single-dos surfact regimen studi sever respiratori distress hour treatment major pulmonari morbid intracrani hemorrhag prematur neonat rd further studi treatment birth rd use multipl dose surfact addit benefit